¼¼°èÀÇ °ÇÁ¶Áõ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Xerosis Treatment Global Market Report 2025
»óǰÄÚµå : 1760746
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,263,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,052,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,842,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°ÇÁ¶Áõ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö 5.4%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 116¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº Àα¸ °í·ÉÈ­, ȯ°æ ¿À¿° Áõ°¡, ÇǺΠ°ü¸® ½À°ü °³¼±¿¡ ´ëÇÑ °ü½É Áõ°¡, ÇǺΠ°ü·Ã °Ç°­ ¹®Á¦ Áõ°¡, °³ÀÎ¿ë ½ºÅ²Äɾî Á¦Ç° äÅà Áõ°¡ µîÀÇ ¿äÀο¡ ±âÀÎÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±¹¼Ò Ä¡·áÀÇ ¹ßÀü, º¸½ÀÁ¦ ó¹æ ±â¼ú °³¼±, ó¹æ ±â¹Ý ½ºÅ²ÄÉ¾î ¼Ö·ç¼ÇÀÇ Çõ½Å, »õ·Î¿î Ä¡·á¹ý ÀÓ»ó½ÃÇèÀÇ ¹ßÀü, ¿þ¾î·¯ºí ½ºÅ²ÄÉ¾î ±â±â °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

°ÇÁ¶Áõ Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀå Àü¸ÁÀº ÀÇ·áºñ ÁöÃâ Áõ°¡¿¡ Å©°Ô ±âÀÎÇÕ´Ï´Ù. ÇコÄɾî ÁöÃâÀº °³ÀÎ, Á¤ºÎ, Á¶Á÷ÀÌ ¿¹¹æ, Áø´Ü, Ä¡·á, Áúº´ °ü¸®¿Í °°Àº ÇコÄÉ¾î ¼­ºñ½º¿¡ ÇÒ´çÇÏ´Â ÃÑ ÀÚ¿øÀ» ÀǹÌÇÕ´Ï´Ù. ÀÇ·á±â¼úÀÇ ¹ßÀü¿¡ µû¶ó »õ·Î¿î Áø´Ü µµ±¸¿Í Ä¡·á¹ýÀº ³ôÀº °³¹ßºñ, µµÀÔºñ, Áö¼ÓÀûÀÎ Ä¡·áºñ°¡ ¼Ò¿äµÇ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ÀÇ·áºñ¿ëÀº Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁöÃâ Áõ°¡´Â ÇǺΰú ÀÇ·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ã۰í, Àü¹®°¡ Áö¿ø ¹× °í±Þ Ä¡·á ¿É¼ÇÀ» ÅëÇØ °ÇÁ¶Áõ Á¶±â Áø´Ü ¹× Áö¼ÓÀûÀÎ °ü¸®¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 5¿ù ¿µ±¹ Åë°èûÀº 2023³â ÃÑ ÀÇ·áºñ ÁöÃâÀÌ 5.6% Áõ°¡Çϰí 2022³â Àå±â ÀÇ·á ¹× »çȸ º¸Àå ÁöÃâÀÌ ½ÇÁú ±âÁØÀ¸·Î 2.8% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ±× °á°ú, ÀÇ·áºñ ÁöÃâ Áõ°¡´Â °ÇÁ¶Áõ Ä¡·á ½ÃÀåÀÇ È®ÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

°ÇÁ¶Áõ Ä¡·áÁ¦ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ÇǺΠÀ庮 ±â´ÉÀ» °³¼±ÇÏ°í °Ç¼º ÇǺΠ»óŸ¦ ´õ Àß °ü¸®Çϱâ À§ÇØ ´õ ¿À·¡ Áö¼ÓµÇ´Â º¸½ÀÀ» Á¦°øÇÏ´Â ¼ÒÇÁÆ® ·Î¼Ç°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ® ·Î¼ÇÀº ÇǺο¡ ºÎµå·´°Ô ¼öºÐÀ» °ø±ÞÇϵµ·Ï ¼³°èµÈ °¡º±°í ²öÀûÀÓÀÌ ¾ø´Â º¸½ÀÁ¦·Î, ¹Î°¨¼º ¹× ÀÏ¹Ý ÇǺÎÀÇ ÀÏ»óÀûÀÎ »ç¿ë¿¡ ÀûÇÕÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 2¿ù Àεµ Á¦¾àȸ»ç Ä«µð¶ó ÆÄ¸¶½´Æ¼Äýº(Kadira Pharmaceuticals)´Â ´Ù¾çÇÑ °Ç¼º ÇǺΠÁúȯÀ» Ä¡·áÇÒ ¼ö ÀÖ´Â ¶ó±×·Î ¼ÒÇÁÆ® ·Î¼ÇÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ·Î¼ÇÀº °ÇÁ¶Áõ, ¾î·ç·¯±â, ¾ÆÅäÇÇ ÇǺο°, °ÇÁ¶Áõ µîÀÇ Áúȯ¿¡ È¿°úÀûÀÔ´Ï´Ù. ¶ÇÇÑ ÇǺΠ³ëÈ­¿¡µµ È¿°ú°¡ ÀÖÀ¸¸ç, ºÎ½ÅÇÇÁú ½ºÅ×·ÎÀ̵å¿Í ÇÔ²² »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Æ÷¹Ä·¯´Â ±íÀº º¸½ÀÀ» Á¦°øÇϰí ÇǺÎÀÇ Àü¹ÝÀûÀÎ °Ç°­À» ÁõÁø½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÔÁõµÈ È¿´ÉÀ» °¡Áø ¶ó±× ±Û·Î¿ì ¼ÒÇÁÆ® ·Î¼ÇÀº ÇǺΠ°ü¸®¸¦ À§ÇÑ Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í ÄڷγªÀç³­°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Xerosis treatment aims to restore moisture to the skin and repair the skin barrier to alleviate dryness, flaking, and discomfort. This typically involves the use of emollients and moisturizers to hydrate the skin and prevent further water loss. Additionally, gentle skin care practices, such as using mild, fragrance-free cleansers and avoiding hot water or aggressive scrubbing, are essential.

The primary treatments for xerosis include medications and personal care products. Medications are substances or compounds used to diagnose, treat, prevent, or manage medical conditions. These are available in various forms, including tablets, lotions, creams, ointments, and shower products. Medications help address symptoms such as roughness, tightness, itching, and flaky skin, and are used in settings including hospitals, clinics, and home care environments.

The xerosis treatment market research report is one of a series of new reports from The Business Research Company that provides xerosis treatment market statistics, including xerosis treatment global market size, regional shares, competitors with a xerosis treatment market share, xerosis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the xerosis treatment. This xerosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xerosis treatment market size has grown strongly in recent years. It will grow from $8.96 billion in 2024 to $9.47 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth observed during the historical period can be attributed to several factors, including the increasing prevalence of dry skin conditions, growing awareness about skin health, a rise in dermatological consultations, greater availability of over-the-counter moisturizers, and a growing demand for natural and organic skincare products.

The xerosis treatment market size is expected to see strong growth in the next few years. It will grow to $11.69 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth projected during the forecast period can be attributed to factors such as an aging population, rising environmental pollution, an increased focus on improving skincare routines, a rise in skin-related health concerns, and a growing adoption of personalized skincare products. Key trends expected in the forecast period include advancements in topical treatments, improved formulation technologies for moisturizers, innovation in prescription-based skincare solutions, progress in clinical trials for new therapies, and the development of wearable skincare devices.

The projected growth of the xerosis treatment market is largely attributed to the rising healthcare expenditure. Healthcare expenditure refers to the total resources allocated to health services, including prevention, diagnosis, treatment, and disease management, by individuals, governments, and organizations. With advancements in medical technology, healthcare costs are increasing as newer diagnostic tools and treatments often involve higher development, implementation, and ongoing care costs. This increased spending enhances access to dermatological care, facilitating early diagnosis and ongoing management of xerosis through professional support and advanced treatment options. For example, in May 2024, the UK's Office for National Statistics reported that total healthcare spending grew by 5.6% in 2023, while long-term health and social care expenditure rose by 2.8% in real terms in 2022. As a result, the growing healthcare expenditure is driving the expansion of the xerosis treatment market.

Leading companies in the xerosis treatment market are focusing on developing innovative solutions, such as soft lotions, to improve skin barrier function and provide longer-lasting hydration for better management of dry skin conditions. Soft lotion is a lightweight, non-greasy moisturizing formula designed to gently hydrate the skin, making it ideal for daily use on sensitive or normal skin types. For example, in February 2022, Cadila Pharmaceuticals, a pharmaceutical company based in India, introduced Laglo Soft Lotion, formulated to treat a range of dry skin conditions. This lotion is effective in managing disorders such as xerosis, ichthyosis, atopic dermatitis, and psoriasis. It also helps with skin aging and can be used alongside corticosteroids as a co-therapy. The formula aims to offer deep hydration and enhance overall skin health. With its proven effectiveness, Laglo Soft Lotion provides a comprehensive solution for skincare.

In January 2022, Galderma, a Switzerland-based pharmaceutical company, acquired ALASTIN Skincare Inc. for an undisclosed amount. This acquisition was intended to enhance Galderma's dermatology portfolio by incorporating ALASTIN's innovative, physician-recommended skincare products, which complement Galderma's existing offerings. The move also aimed to accelerate ALASTIN's growth by leveraging Galderma's global reach and resources to expand its presence with healthcare professionals and consumers. ALASTIN Skincare Inc. is a US-based company, offering a range of products focused on treating and managing xerosis (dry skin), with an emphasis on hydration, barrier repair, and overall skin health.

Major players in the xerosis treatment market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Unilever PLC, Bayer AG, Sanofi S.A., L'Oreal S.A., GlaxoSmithKline plc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy's Laboratories Ltd., LEO Pharma A/S, Arcutis Biotherapeutics Inc., Neutrogena, Aveeno, CeraVe, La Roche-Posay, Nivea, and Cetaphil.

North America was the largest region in the xerosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in xerosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the xerosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xerosis treatment market consists of sales of cleansing bars, body oils and barrier repair creams. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xerosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xerosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for xerosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The xerosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Xerosis Treatment Market Characteristics

3. Xerosis Treatment Market Trends And Strategies

4. Xerosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Xerosis Treatment Growth Analysis And Strategic Analysis Framework

6. Xerosis Treatment Market Segmentation

7. Xerosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Xerosis Treatment Market

9. China Xerosis Treatment Market

10. India Xerosis Treatment Market

11. Japan Xerosis Treatment Market

12. Australia Xerosis Treatment Market

13. Indonesia Xerosis Treatment Market

14. South Korea Xerosis Treatment Market

15. Western Europe Xerosis Treatment Market

16. UK Xerosis Treatment Market

17. Germany Xerosis Treatment Market

18. France Xerosis Treatment Market

19. Italy Xerosis Treatment Market

20. Spain Xerosis Treatment Market

21. Eastern Europe Xerosis Treatment Market

22. Russia Xerosis Treatment Market

23. North America Xerosis Treatment Market

24. USA Xerosis Treatment Market

25. Canada Xerosis Treatment Market

26. South America Xerosis Treatment Market

27. Brazil Xerosis Treatment Market

28. Middle East Xerosis Treatment Market

29. Africa Xerosis Treatment Market

30. Xerosis Treatment Market Competitive Landscape And Company Profiles

31. Xerosis Treatment Market Other Major And Innovative Companies

32. Global Xerosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Xerosis Treatment Market

34. Recent Developments In The Xerosis Treatment Market

35. Xerosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â